Literature DB >> 8578600

Fos and bone cell development: lessons from a nuclear oncogene.

A E Grigoriadis, Z Q Wang, E F Wagner.   

Abstract

Vertebrate embryologists are beginning to understand the early developmental decisions that control the origin and patterning of skeletal elements. However, the regulators governing the development of the cells that form the skeleton, namely, bone and cartilage cells, are poorly understood. Recent studies using transgenic and knockout mice have established a unique role for the proto-oncogene and nuclear transcription factor, Fos, in regulating the differentiation and activity of specific bone cell populations, both during normal development and in bone disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578600     DOI: 10.1016/s0168-9525(00)89142-8

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  10 in total

1.  GATA-Dependent expression of the interleukin-1 receptor-related T1 gene in mast cells.

Authors:  T Gächter; D R Moritz; J Gheyselinck; R Klemenz
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

2.  Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription.

Authors:  A Moreau; W V Yotov; F H Glorieux; R St-Arnaud
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

3.  Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.

Authors:  M Orlandini; L Marconcini; R Ferruzzi; S Oliviero
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).

Authors:  M G Achen; M Jeltsch; E Kukk; T Mäkinen; A Vitali; A F Wilks; K Alitalo; S A Stacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

5.  Antagonist minigenes identify genes regulated by parathyroid hormone through G protein-selective and G protein co-regulated mechanisms in osteoblastic cells.

Authors:  J Wang; A Gilchrist; P H Stern
Journal:  Cell Signal       Date:  2010-10-19       Impact factor: 4.315

6.  Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

Authors:  Virna D Leaner; Jeffrey F Chick; Howard Donninger; Ilona Linniola; Arnulfo Mendoza; Chand Khanna; Michael J Birrer
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

7.  Fuzzy clustering analysis of osteosarcoma related genes.

Authors:  Kai Chen; Dajiang Wu; Yushu Bai; Xiaodong Zhu; Ziqiang Chen; Chuanfeng Wang; Yingchuan Zhao; Ming Li
Journal:  Pathol Oncol Res       Date:  2013-11-30       Impact factor: 3.201

8.  Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor.

Authors:  Taranpreet K Chandhoke; Yu-Feng Huang; Fei Liu; Gloria A Gronowicz; Douglas J Adams; John R Harrison; Barbara E Kream
Journal:  Bone       Date:  2008-03-29       Impact factor: 4.398

Review 9.  PTH and PTHrP signaling in osteoblasts.

Authors:  Nabanita S Datta; Abdul B Abou-Samra
Journal:  Cell Signal       Date:  2009-02-26       Impact factor: 4.315

10.  Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3.

Authors:  K N Weilbaecher; C L Hershey; C M Takemoto; M A Horstmann; T J Hemesath; A H Tashjian; D E Fisher
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.